Short answer · Medically reviewed summary · Last updated: 2026-05-08
Cardiofaciocutaneous (CFC) syndrome is a rare genetic disorder characterized by a triad of distinctive facial features, heart defects, and skin abnormalities. Diagnosis is confirmed through molecular genetic testing that identifies a pathogenic variant in the BRAF, MAP2K1, MAP2K2, or KRAS genes, which are part of the RAS/MAPK pathway. What are the early signs of Cardiofaciocutaneous syndrome? In infancy, Cardiofaciocutaneous syndrome often presents with failure to thrive, feeding difficulties, and macrocephaly (an enlarged head).
Cardiofaciocutaneous (CFC) syndrome is a rare genetic disorder characterized by a triad of distinctive facial features, heart defects, and skin abnormalities. Diagnosis is confirmed through molecular genetic testing that identifies a pathogenic variant in the BRAF, MAP2K1, MAP2K2, or KRAS genes, which are part of the RAS/MAPK pathway.
In infancy, Cardiofaciocutaneous syndrome often presents with failure to thrive, feeding difficulties, and macrocephaly (an enlarged head). Clinicians look for a specific "facial gestalt," including high forehead, bitemporal narrowing, and down-slanting palpebral fissures. You may also notice sparse, brittle hair and skin conditions like ichthyosis or keratosis pilaris.
If you suspect Cardiofaciocutaneous syndrome, a clinical evaluation by a geneticist is essential. Diagnosis follows a specific path:
Consult a specialist if there is a combination of developmental delay, cardiac anomalies, and unique dermatological findings. When speaking with your doctor, explicitly mention Cardiofaciocutaneous syndrome and ask for a referral to a clinical geneticist. If your concerns are dismissed, bring printed literature from NIH GARD or DiseaseMaps.org to demonstrate the clinical validity of your request.
While many children exhibit minor developmental delays or facial variations, Cardiofaciocutaneous syndrome involves a consistent pattern of systemic involvement across the heart, skin, and neurological systems. Unlike normal variations, these symptoms are typically progressive or persistent and originate from a specific underlying genetic mutation.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.